HF
TSHA icon

HRT Financial’s Taysha Gene Therapies TSHA Stock Holding History

HRT Financial’s Portfolio TSHA Stock Details TSHA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-409,254
Closed -$2.25M – 4750
2025
Q4 		$2.25M Buy
+409,254
New +$1.99M 0.01% 1229
2025
Q2 		– Sell
-139,692
Closed -$194K – 3530
2025
Q1 		$194K Buy
+139,692
New +$234K ﹤0.01% 2041
2024
Q2 		– Sell
-414,980
Closed -$1.19M – 3122
2024
Q1 		$1.19M Buy
+414,980
New +$865K 0.01% 805
2021
Q2 		– Sell
-12,239
Closed -$248K – 3541
2021
Q1 		$248K Buy
+12,239
New +$331K ﹤0.01% 2203

Other funds holding TSHA

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM